##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H108-301222-ROCHE_S56_R
1	18291866	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=43146;GeneNames=IGSF21;GeneIDs=84966;Genes=1;TranscriptNameClinicallyRelevant=NM_032880.5;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000001.11:g.18291866_18335011dup;HGVScClinicallyRelevant=NM_032880.5:c.184_424+1dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=18335011	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:89.9208:3.7835:1.5:1.64198341596981e-05:IGSF21::IGSF21:NM_032880.5:VUS:2L0ThiscnvpartiallyoverlapstheIGSF21genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	26411356	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=256;GeneNames=LIN28A;GeneIDs=79727;Aliases=CSDD1,LIN-28,LIN28,ZCCHC1,lin-28A;Genes=1;TranscriptNameClinicallyRelevant=NM_024674.6;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000001.11:g.26411356_26411611del;HGVScClinicallyRelevant=NM_024674.6:c.32-30_228+29del;HGVSpClinicallyRelevant=NP_078950.1:p.G11Efs*2;ISCNCytobandNotation=del(1)p36.11;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=26411611	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:48.75:-3.23555:0.549685:0.000223793060305548:LIN28A::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
1	31728555	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=ADGRB2;GeneIDs=576;Aliases=BAI2;Genes=1;TranscriptNameClinicallyRelevant=NM_001364857.2;OverlappingExonsClinicallyRelevant=30;HGVSg=NC_000001.11:g.31728555_31728674dup;HGVScClinicallyRelevant=NM_001364857.2:c.4381-41_4416+43dup;HGVSpClinicallyRelevant=NP_001351786.1:p.R1461_E1472dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31728674	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:134.2:4.56836:1.64801:0.000239712883111303:ADGRB2::ADGRB2:NM_001364857.2:VUS:2L0ThiscnvpartiallyoverlapstheADGRB2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	31742828	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=1922;GeneNames=ADGRB2;GeneIDs=576;Aliases=BAI2;Genes=1;TranscriptNameClinicallyRelevant=NM_001364857.2;OverlappingExonsClinicallyRelevant=5-7;HGVSg=NC_000001.11:g.31742828_31744749dup;HGVScClinicallyRelevant=NM_001364857.2:c.839-18_1252+10dup;HGVSpClinicallyRelevant=NP_001351786.1:p.G280_P417dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31744749	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:127.293:3.33042:1.40657:3.36364953119251e-06:ADGRB2::ADGRB2:NM_001364857.2:VUS:2L0ThiscnvpartiallyoverlapstheADGRB2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	46572055	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=11283;GeneNames=MKNK1;GeneIDs=8569;Aliases=MNK1;Genes=1;TranscriptNameClinicallyRelevant=NM_001135553.4;OverlappingExonsClinicallyRelevant=3-7;HGVSg=NC_000001.11:g.46572055_46583337dup;HGVScClinicallyRelevant=NM_001135553.4:c.1_457+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=46583337	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:90.8833:2.37902:1.3789:1.87264217957948e-05:MKNK1::MKNK1:NM_001135553.4:VUS:2L0ThiscnvpartiallyoverlapstheMKNK1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	75242888	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=8424;GeneNames=SLC44A5;GeneIDs=204962;Aliases=CTL5;Genes=1;TranscriptNameClinicallyRelevant=NM_001130058.2;OverlappingExonsClinicallyRelevant=7-8;HGVSg=NC_000001.11:g.75242888_75251311dup;HGVScClinicallyRelevant=NM_001130058.2:c.261-17_469dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p31.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=75251311	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:63.7125:3.09115:1.45794:0.000447520964134791:SLC44A5::SLC44A5:NM_001130058.2:VUS:2L0ThiscnvpartiallyoverlapstheSLC44A5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	180175922	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=2978;GeneNames=QSOX1;GeneIDs=5768;Aliases=Q6,QSCN6;Genes=1;TranscriptNameClinicallyRelevant=NM_002826.5;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000001.11:g.180175922_180178899dup;HGVScClinicallyRelevant=NM_002826.5:c.413-9_606+15dup;HGVSpClinicallyRelevant=NP_002817.2:p.V203Wfs*53;ISCNCytobandNotation=dup(1)q25.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=180178899	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:81.1917:3.50165:1.56526:6.77650159558337e-05:QSOX1::QSOX1:NM_002826.5:VUS:2L0ThiscnvpartiallyoverlapstheQSOX1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	228340504	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=394;GeneNames=OBSCN;GeneIDs=84033;Aliases=ARHGEF30,UNC89;Genes=1;TranscriptNameClinicallyRelevant=NM_052843.4;OverlappingExonsClinicallyRelevant=71-72;HGVSg=NC_000001.11:g.228340504_228340897dup;HGVScClinicallyRelevant=NM_052843.4:c.17416-2_17697+9dup;HGVSpClinicallyRelevant=NP_443075.3:p.K5806_Q5899dup;ISCNCytobandNotation=dup(1)q42.13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=228340897	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.03:3.30524:1.4483:0.000171623741414729:OBSCN::OBSCN:NM_052843.4:VUS:2L0ThiscnvpartiallyoverlapstheOBSCNgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
4	9174443	.	N	<DUP>	.	.	Type=Gain;Targets=20;Samples2=3;Span=270179;GeneNames=DEFB131A,FAM90A26,USP17L5,USP17L6P,USP17L9P,USP17L10,USP17L11,USP17L12,USP17L13,USP17L15,USP17L17,USP17L18,USP17L19,USP17L20,USP17L21,USP17L22,USP17L24,USP17L25,USP17L26,USP17L27,USP17L28,USP17L29,USP17L30;GeneIDs=100287045,100287144,100287178,100287205,100287238,100288520,100287327,100287364,100287404,100287441,100287478,100287513,728369,728373,728379,728386,728393,728400,728405,391627,728419,391622,644414;Aliases=FAM90A26P;Genes=23;TranscriptNameClinicallyRelevant=NM_001040448.3,NM_001358418.3,NM_001242329.1,NR_027279.1,NR_046416.1,NM_001256852.1,NM_001256854.1,NM_001256853.1,NM_001256855.1,NM_001256894.2,NM_001256857.1,NM_001256859.1,NM_001256860.1,NM_001256861.1,NM_001256862.1,NM_001256863.1,NM_001242327.1,NM_001242326.1,NM_001242328.1,NM_001242330.1,NM_001242331.1,NM_001242332.1,NM_001256867.1;OverlappingExonsClinicallyRelevant=1,6-7,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All;HGVSg=NC_000004.12:g.9174443_9444621dup;HGVScClinicallyRelevant=NM_001040448.3:c.1_58+30dup,NM_001358418.3:c.324-5_1395dup,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(4)p16.1;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;RegionClinicallyRelevant=exon,exon,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;Region=4:8701383-9499656,4:9322956-9410804,4:9322956-9519119,4:9366693-9455251;Span2=798274,87849,196164,88559;OverlapType=Within Region,Contains Region,Partial Overlap,Partial Overlap;Name=gssvG27132,gssvG27152,gssvG27142,gssvG27154;Frequency=0.0011,0.8235,0.0353,0.0046;Type2=Gain,Gain,Gain,Gain;Region2=4:9322957-9490553,4:9322968-9406588;Span3=167597,83621;OverlapType2=Partial Overlap,Contains Region;Type3=Duplication,Duplication;Frequency2=0.15,0.75;DeletionFrequency=0,0;DuplicationFrequency=0.15,0.75;END=9444621	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:167.908:1.98704:2.46968:7.70497516275012e-13:DEFB131A,FAM90A26,USP17L5,USP17L6P,USP17L9P,USP17L10,USP17L11,USP17L12,USP17L13,USP17L15,USP17L17,USP17L18,USP17L19,USP17L20,USP17L21,USP17L22,USP17L24,USP17L25,USP17L26,USP17L27,USP17L28,USP17L29,USP17L30::USP17L5:NM_001242329.1:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46597inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps21proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
4	154545819	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=410;GeneNames=PLRG1;GeneIDs=5356;Aliases=Cwc1,PRL1,PRP46,PRPF46,TANGO4;Genes=1;TranscriptNameClinicallyRelevant=NM_002669.4;OverlappingExonsClinicallyRelevant=5-6;HGVSg=NC_000004.12:g.154545819_154546228dup;HGVScClinicallyRelevant=NM_002669.4:c.314-15_492+17dup;HGVSpClinicallyRelevant=NP_002660.1:p.I165Gfs*4;ISCNCytobandNotation=dup(4)q31.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=154546228	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.225:3.07465:1.42792:0.000480700251096504:PLRG1::PLRG1:NM_002669.4:VUS:2L0ThiscnvpartiallyoverlapsthePLRG1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	139329535	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=1032;GeneNames=MATR3;GeneIDs=9782;Aliases=ALS21,MPD2,VCPDM;Genes=1;TranscriptNameClinicallyRelevant=NM_199189.3;OverlappingExonsClinicallyRelevant=18;HGVSg=NC_000005.10:g.139329535_139330566dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(5)q31.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=139330566	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:135.552:2.67975:1.30843:1.38721574081698e-06:MATR3::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
6	31269075	.	N	<DUP>	.	.	Type=Gain;Targets=15;Samples2=2;Span=134652;GeneNames=HLA-B,HLA-C,LINC02571,MICA,MICA-AS1,MIR6891;GeneIDs=3107,105375015,3106,102465537,101929072,100507436;Aliases=D6S204,HLA-JY3,HLAC,HLC-C,MHC,PSORS1;Genes=6;TranscriptNameClinicallyRelevant=NM_005514.8,NM_002117.6,NR_149115.1,NM_001177519.3,NR_148223.1,NR_106951.1;OverlappingExonsClinicallyRelevant=All,All,All,1,All,All;HGVSg=NC_000006.12:g.31269075_31403726dup;HGVScClinicallyRelevant=.,.,.,NM_001177519.3:c.1_70+24dup,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation,.,.;RegionClinicallyRelevant=.,.,.,exon,.,.;Region=6:31260502-31372067,6:31306468-31352155,6:31312324-31383876,6:31359183-31398092;Span2=111566,45688,71553,38910;OverlapType=Partial Overlap,Contains Region,Contains Region,Contains Region;Name=gssvG32008,gssvG32011,gssvG32009,gssvG32012;Frequency=0.0012,0.0087,0.2089,0.0006;Type2=Gain,Gain,Gain,Gain;Region2=6:31317275-31346024,6:31317870-31383797;Span3=28750,65928;OverlapType2=Contains Region,Contains Region;Type3=Duplication,Duplication;Frequency2=0.6,0.05;DeletionFrequency=0,0;DuplicationFrequency=0.6,0.05;END=31403726	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:168.223:2.42063:2.37061:3.83550439665391e-14:HLA-B,HLA-C,LINC02571,MICA,MICA-AS1,MIR6891::MICA:NM_001177519.3:VUS:2L0ThiscnvpartiallyoverlapstheMICAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	32637440	.	N	<DEL>	.	.	Type=Loss;Targets=11;Samples2=2;Span=27469;GeneNames=HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1;GeneIDs=3117,3119,106480429;Aliases=CELIAC1,DQ-A1,DQA1,HLA-DQA;Genes=3;TranscriptNameClinicallyRelevant=NM_002122.5,NM_002123.5,NR_133907.1;OverlappingExonsClinicallyRelevant=All,2-5,All;HGVSg=NC_000006.12:g.32637440_32664908del;HGVScClinicallyRelevant=.,NM_002123.5:c.269_786del,.;HGVSpClinicallyRelevant=.,NP_002114.3:p.E91Pext*12,.;ISCNCytobandNotation=del(6)p21.32;SequenceOntologyClinicallyRelevant=.,stop_lost,.;RegionClinicallyRelevant=.,exon,.;Region=6:32602269-32667519,6:32623907-32646260,6:32631568-32664223,6:32635668-32687441,6:32637159-32648355,6:32642665-32658151;Span2=65251,22354,32656,51774,11197,15487;OverlapType=Within Region,Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Contains Region;Name=gssvL106261,gssvL106274,gssvL106270,gssvL106263,gssvL106287,gssvL106284;Frequency=0.0297,0.1048,0.3684,0.0171,0.5606,0.0565;Type2=Loss,Loss,Loss,Loss,Loss,Loss;Region2=6:32603525-32658123;Span3=54599;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.012685;DeletionFrequency=0.012685;DuplicationFrequency=0;END=32664908	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:17.7643:-1.74148:0.254384:2.90792483118893e-06:HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1::HLA-DQA1:NM_002122.5:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46611inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
7	73308432	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=372;GeneNames=NSUN5;GeneIDs=55695;Aliases=NOL1,NOL1R,NSUN5A,WBSCR20,WBSCR20A,p120,p120(NOL1);Genes=1;TranscriptNameClinicallyRelevant=NM_148956.4;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000007.14:g.73308432_73308803dup;HGVScClinicallyRelevant=NM_148956.4:c.1_215dup;HGVSpClinicallyRelevant=NP_683759.1:p.V73Wfs*33;ISCNCytobandNotation=dup(7)q11.23;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=73308803	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:69.0292:3.5775:1.44271:4.67301422141864e-05:NSUN5::NSUN5:NM_148956.4:VUS:2L0ThiscnvpartiallyoverlapstheNSUN5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	74521192	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=GTF2IRD1;GeneIDs=9569;Aliases=BEN,CREAM1,GTF3,MUSTRD1,RBAP2,WBS,WBSCR11,WBSCR12,hMusTRD1alpha1;Genes=1;TranscriptNameClinicallyRelevant=NM_016328.3;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000007.14:g.74521192_74521311dup;HGVScClinicallyRelevant=NM_016328.3:c.917-16_1006+14dup;HGVSpClinicallyRelevant=NP_057412.1:p.G306_S335dup;ISCNCytobandNotation=dup(7)q11.23;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=74521311	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.775:5.11573:1.7511:3.79972465705815e-05:GTF2IRD1::GTF2IRD1:NM_016328.3:VUS:2B0WhiletheCNVoverlapstheGTF2IRD1geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37392inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheGTF2IRD1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	75404809	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=3;Span=446;GeneNames=TRIM73;GeneIDs=375593;Aliases=TRIM50B;Genes=1;TranscriptNameClinicallyRelevant=NM_198924.4;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000007.14:g.75404809_75405254del;HGVScClinicallyRelevant=NM_198924.4:c.496-30_753del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q11.23;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=75405254	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:33.5931:-3.08855:0.509042:0.000430244084900244:TRIM73::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
7	100734135	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=7;Span=4487;GeneNames=ZAN;GeneIDs=7455;Genes=1;TranscriptNameClinicallyRelevant=NM_003386.3;OverlappingExonsClinicallyRelevant=2-7;HGVSg=NC_000007.14:g.100734135_100738621del;HGVScClinicallyRelevant=NM_003386.3:c.1_766+8del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=7:100728772-100746736,7:100730191-100740263;Span2=17965,10073;OverlapType=Within Region,Within Region;Name=gssvL117703,gssvL117715;Frequency=0.1717,0.1248;Type2=Loss,Loss;Region2=7:100729694-100744887,7:100730240-100745592,7:100730247-100745036;Span3=15194,15353,14790;OverlapType2=Within Region,Within Region,Within Region;Type3=Deletion,Deletion,Deletion;Frequency2=0.411205,0.333333,0.375;DeletionFrequency=0.411205,0.333333,0.375;DuplicationFrequency=0,0,0;END=100738621	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.95534:0:4.55805596527007e-09:ZAN::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:0
7	142345443	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=8;Span=4231;END=142349673	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:359.022:3.16272:1.59551:1.02947720088081e-05:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
10	46306778	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=2453;GeneNames=ANTXRL;GeneIDs=195977;Genes=1;TranscriptNameClinicallyRelevant=NM_001278688.3;OverlappingExonsClinicallyRelevant=11-13;HGVSg=NC_000010.11:g.46306778_46309230dup;HGVScClinicallyRelevant=NM_001278688.3:c.896-25_1134+28dup;HGVSpClinicallyRelevant=NP_001265617.1:p.T379Mfs*12;ISCNCytobandNotation=dup(10)q11.22;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=46309230	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.882:2.44134:1.36354:8.68584249715494e-05:ANTXRL::ANTXRL:NM_001278688.3:Benign:2L0ThiscnvpartiallyoverlapstheANTXRLgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
10	97381375	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=RRP12;GeneIDs=23223;Aliases=KIAA0690;Genes=1;TranscriptNameClinicallyRelevant=NM_015179.4;OverlappingExonsClinicallyRelevant=12;HGVSg=NC_000010.11:g.97381375_97381494dup;HGVScClinicallyRelevant=NM_015179.4:c.1321-11_1418+11dup;HGVSpClinicallyRelevant=NP_055994.2:p.A474Rfs*3;ISCNCytobandNotation=dup(10)q24.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=97381494	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:113.758:4.62377:1.66112:0.000200625101294009:RRP12::RRP12:NM_015179.4:VUS:2L0ThiscnvpartiallyoverlapstheRRP12genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	408079	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1218;GeneNames=SIGIRR;GeneIDs=59307;Aliases=IL-1R8,TIR8;Genes=1;TranscriptNameClinicallyRelevant=NM_001135054.2;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000011.10:g.408079_409296dup;HGVScClinicallyRelevant=NM_001135054.2:c.8-403_334dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(11)p15.5;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=409296	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:123.449:2.85553:1.38478:6.965350476454e-05:SIGIRR::SIGIRR:NM_001135054.2:VUS:2L0ThiscnvpartiallyoverlapstheSIGIRRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	117228223	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=4;Span=1630;GeneNames=PCSK7;GeneIDs=9159;Aliases=LPC,PC7,PC8,SPC7;Genes=1;TranscriptNameClinicallyRelevant=NM_004716.4;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000011.10:g.117228223_117229852dup;HGVScClinicallyRelevant=NM_004716.4:c.1_596dup;HGVSpClinicallyRelevant=NP_004707.2:p.N200Cfs*25;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=117229852	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:161.727:3.37478:1.36551:0.000124189656489362:PCSK7::PCSK7:NM_004716.4:VUS:2L0ThiscnvpartiallyoverlapsthePCSK7genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	6934462	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=ATN1;GeneIDs=1822;Aliases=B37,CHEDDA,D12S755E,DRPLA,HRS,NOD;Genes=1;TranscriptNameClinicallyRelevant=NM_001007026.2;OverlappingExonsClinicallyRelevant=4;HGVSg=NC_000012.12:g.6934462_6934581dup;HGVScClinicallyRelevant=NM_001007026.2:c.166-3_279+3dup;HGVSpClinicallyRelevant=NP_001007027.1:p.K56_E93dup;ISCNCytobandNotation=dup(12)p13.31;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=6934581	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:145.542:4.49:1.6308:0.000307321546085808:ATN1::ATN1:NM_001007026.2:VUS:2L0ThiscnvpartiallyoverlapstheATN1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	50181911	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=13996;GeneNames=LIMA1;GeneIDs=51474;Aliases=EPLIN,LDLCQ8,SREBP3;Genes=1;TranscriptNameClinicallyRelevant=NM_016357.5;OverlappingExonsClinicallyRelevant=8-10;HGVSg=NC_000012.12:g.50181911_50195906del;HGVScClinicallyRelevant=NM_016357.5:c.973-19_1267del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(12)q13.12;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=50195906	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:49.5083:-3.01835:0.616861:2.40342600263669e-05:LIMA1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
12	57479699	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=9426;GeneNames=ARHGAP9,MARS1;GeneIDs=64333,4141;Aliases=10C;Genes=2;TranscriptNameClinicallyRelevant=NM_032496.4,NM_004990.4;OverlappingExonsClinicallyRelevant=1,1-2;HGVSg=NC_000012.12:g.57479699_57489124dup;HGVScClinicallyRelevant=.,NM_004990.4:c.1_200+15dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(12)q13.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=57489124	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.845:2.94654:1.34624:1.08537926665852e-07:ARHGAP9,MARS1::MARS1:NM_004990.4:VUS:2L0ThiscnvpartiallyoverlapstheMARS1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	19747333	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=6;Span=189329;GeneNames=OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3;GeneIDs=441669,441670,390429,283617,390431,79317,79544;Aliases=C14orf13,HSA6,OR14-3,OR4Q4,c14_5008;Genes=7;TranscriptNameClinicallyRelevant=NM_001004063.3,NM_001005501.2,NR_145507.2,NM_001005483.1,NM_001005500.2,NM_001004723.3,NM_172194.1;OverlappingExonsClinicallyRelevant=All,All,All,All,All,All,All;HGVSg=NC_000014.9:g.19747333_19936661dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(14)q11.2;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.,.,.;Region=14:19709051-19977459,14:19716201-19874569,14:19726341-19808815,14:19791588-19956892,14:19797476-19873135,14:19851530-19957689;Span2=268409,158369,82475,165305,75660,106160;OverlapType=Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG10817,gssvG10821,gssvG10829,gssvG10825,gssvG10838,gssvG10827;Frequency=0.0677,0.0004,0.0006,0.0009,0.0002,0.1048;Type2=Gain,Gain,Gain,Gain,Gain,Gain;Region2=14:19704993-19947632,14:19709052-19956594,14:19726698-19833781,14:19732025-19813305,14:19795943-19845066,14:19894662-19955213;Span3=242640,247543,107084,81281,49124,60552;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.415273,0.531111,0.125,0.00101369,0.1,0.00118263;DeletionFrequency=0,0,0,0,0,0;DuplicationFrequency=0.415273,0.531111,0.125,0.00101369,0.1,0.00118263;END=19936661	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:378.198:1.925:1.43311:3.37419967911475e-06:OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3::OR4K1:NM_001004063.3:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-46679inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	105907139	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=20;Span=7272;Region=14:105895622-105912944,14:105904771-105917142;Span2=17323,12372;OverlapType=Partial Overlap,Within Region;Name=gssvL37273,gssvL37314;Frequency=0.1145,0.0417;Type2=Loss,Loss;Region2=14:105895696-105916947,14:105907304-105916494,14:105908863-105910510,14:105908955-105910510;Span3=21252,9191,1648,1556;OverlapType2=Within Region,Partial Overlap,Contains Region,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion;Frequency2=0.325,0.1,0.00236686,0.00118343;DeletionFrequency=0.325,0.1,0.00236686,0.00118343;DuplicationFrequency=0,0,0,0;END=105914410	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.253:0:8.04962081704687e-06:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37477inClinGenDosageSensitivity.,3A0Thiscnvoverlaps0proteincodinggenes:0
16	4726660	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=3498;GeneNames=ANKS3;GeneIDs=124401;Genes=1;TranscriptNameClinicallyRelevant=NM_133450.4;OverlappingExonsClinicallyRelevant=3-5;HGVSg=NC_000016.10:g.4726660_4730157dup;HGVScClinicallyRelevant=NM_133450.4:c.1_490dup;HGVSpClinicallyRelevant=NP_597707.1:p.R164Nfs*7;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=4730157	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:118.873:3.10209:1.37189:1.52266507909138e-05:ANKS3::ANKS3:NM_133450.4:VUS:2L0ThiscnvpartiallyoverlapstheANKS3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	24556318	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=RBBP6;GeneIDs=5930;Aliases=MY038,P2P-R,PACT,RBQ-1,SNAMA;Genes=1;TranscriptNameClinicallyRelevant=NM_006910.5;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000016.10:g.24556318_24556437dup;HGVScClinicallyRelevant=NM_006910.5:c.544_545ins(120);HGVSpClinicallyRelevant=NP_008841.2:p.P221_T222ins40;ISCNCytobandNotation=dup(16)p12.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=24556437	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:80.525:4.66119:1.63525:0.000177713503703334:RBBP6::RBBP6:NM_006910.5:VUS:2L0ThiscnvpartiallyoverlapstheRBBP6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	88650925	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CYBA;GeneIDs=1535;Aliases=CGD4,p22-PHOX;Genes=1;TranscriptNameClinicallyRelevant=NM_000101.4;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000016.10:g.88650925_88651044dup;HGVScClinicallyRelevant=NM_000101.4:c.1_58+31dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)q24.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=88651044	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:76.1333:4.44006:1.6293:0.000359332131485625:CYBA::CYBA:NM_000101.4:VUS:2L0ThiscnvpartiallyoverlapstheCYBAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	36174954	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=1;Span=157448;GeneNames=CCL3L3,CCL4L2,TBC1D3B,TBC1D3G,TBC1D3I;GeneIDs=414059,414062,9560,102724862,101060321;Aliases=PRC17;Genes=5;TranscriptNameClinicallyRelevant=NM_001001437.4,NM_001291475.2,NM_001001417.7,NM_001291462.2,NM_001291463.2;OverlappingExonsClinicallyRelevant=All,All,1-2,1-12,All;HGVSg=NC_000017.11:g.36174954_36332401dup;HGVScClinicallyRelevant=.,.,NM_001001417.7:c.1_72+25dup,NM_001291462.2:c.1_928+12dup,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(17)q12;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=.,.,exon,exon,.;Region=17:36062076-36258922,17:36062076-36348456,17:36078187-36594623,17:36154369-36258902,17:36177443-36348456,17:36180216-36222804,17:36226942-36344206,17:36265348-36297755;Span2=196847,286381,516437,104534,171014,42589,117265,32408;OverlapType=Partial Overlap,Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Contains Region;Name=gssvG16380,gssvG16376,gssvG16370,gssvG16389,gssvG16379,gssvG16405,gssvG16386,gssvG16416;Frequency=0.0331,0.0498,0.0035,0.0034,0.009,0.007,0.24,0.0597;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=17:36081657-36329049,17:36108281-36293667,17:36154492-36348436,17:36177444-36348456;Span3=247393,185387,193945,171013;OverlapType2=Partial Overlap,Partial Overlap,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.45,0.0501774,0.1,0.025;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.45,0.0501774,0.1,0.025;END=36332401	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:173.716:1.68383:1.68928:7.11721185546363e-06:CCL3L3,CCL4L2,TBC1D3B,TBC1D3G,TBC1D3I::CCL3L3:NM_001001437.4:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46706inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps5proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	36503088	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=MYO19;GeneIDs=80179;Aliases=MYOHD1;Genes=1;TranscriptNameClinicallyRelevant=NM_001163735.2;OverlappingExonsClinicallyRelevant=21;HGVSg=NC_000017.11:g.36503088_36503207dup;HGVScClinicallyRelevant=NM_001163735.2:c.1977-7_2080+9dup;HGVSpClinicallyRelevant=NP_001157207.1:p.E694Gfs*8;ISCNCytobandNotation=dup(17)q12;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=36503207	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:93.0917:4.93958:1.84785:7.01488467663852e-05:MYO19::MYO19:NM_001163735.2:VUS:2B0WhiletheCNVoverlapstheMYO19geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37432inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheMYO19genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	41249702	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=26534;GeneNames=KRTAP9-4,KRTAP9-6,KRTAP9-7,KRTAP9-9;GeneIDs=85280,81870,100507608,100505724;Aliases=KAP9.4,KRTAP9.4;Genes=4;TranscriptNameClinicallyRelevant=NM_033191.3,NM_001277331.1,NM_001277332.1,NM_030975.2;OverlappingExonsClinicallyRelevant=All,All,All,All;HGVSg=NC_000017.11:g.41249702_41276235dup;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(17)q21.2;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;Region=17:41231296-41275630,17:41257146-41291759,17:41265420-41277277;Span2=44335,34614,11858;OverlapType=Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvG16524,gssvG16525,gssvG16528;Frequency=0.0016,0.0005,0.035;Type2=Gain,Gain,Gain;END=41276235	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:320.313:2.51154:1.34507:5.36584424958607e-05:KRTAP9-4,KRTAP9-6,KRTAP9-7,KRTAP9-9::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps4proteincodinggenes:3
17	50077353	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1583;GeneNames=ITGA3;GeneIDs=3675;Aliases=CD49C,FRP-2,GAP-B3,GAPB3,ILNEB,JEB7,MSK18,VCA-2,VL3A,VLA3a;Genes=1;TranscriptNameClinicallyRelevant=NM_002204.4;OverlappingExonsClinicallyRelevant=16-19;HGVSg=NC_000017.11:g.50077353_50078935dup;HGVScClinicallyRelevant=NM_002204.4:c.2071-26_2400+9dup;HGVSpClinicallyRelevant=NP_002195.1:p.P691_Q800dup;ISCNCytobandNotation=dup(17)q21.33;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=50078935	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:124.992:3.58965:1.39482:6.91674883080742e-09:ITGA3::ITGA3:NM_002204.4:VUS:2L0ThiscnvpartiallyoverlapstheITGA3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	2418011	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=TMPRSS9;GeneIDs=360200;Genes=1;TranscriptNameClinicallyRelevant=NM_001395513.1;OverlappingExonsClinicallyRelevant=14;HGVSg=NC_000019.10:g.2418011_2418130dup;HGVScClinicallyRelevant=NM_001395513.1:c.2026_2027ins(120);HGVSpClinicallyRelevant=NP_001382442.1:p.E677_S716dup;ISCNCytobandNotation=dup(19)p13.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=2418130	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.558:5.4309:2.01744:1.20860496393016e-05:TMPRSS9::TMPRSS9:NM_001395513.1:VUS:2L0ThiscnvpartiallyoverlapstheTMPRSS9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	39445869	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=6;Span=120;GeneNames=SUPT5H;GeneIDs=6829;Aliases=SPT5,SPT5H,Tat-CT1;Genes=1;TranscriptNameClinicallyRelevant=NM_001111020.3;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000019.10:g.39445869_39445988dup;HGVScClinicallyRelevant=NM_001111020.3:c.1_75+23dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=39445988	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:97.35:5.09654:1.72149:4.06607746210359e-05:SUPT5H::SUPT5H:NM_001111020.3:VUS:2L0ThiscnvpartiallyoverlapstheSUPT5Hgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	42867043	.	N	<DEL>	.	.	Type=Loss;Targets=29;Samples2=1;Span=159374;GeneNames=PSG1,PSG6,PSG7,PSG11;GeneIDs=5669,5675,5676,5680;Aliases=B1G1,CD66f,FL-NCA-1/2,PBG1,PS-beta-C/D,PS-beta-G-1,PSBG-1,PSBG1,PSG95,PSGGA,PSGIIA;Genes=4;TranscriptNameClinicallyRelevant=NM_001184825.2,NM_001031850.4,NM_002783.3,NM_002785.3;OverlappingExonsClinicallyRelevant=All,All,All,All;HGVSg=NC_000019.10:g.42867043_43026416del;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=del(19)q13.2-q13.31;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;Region=19:42634891-43060188,19:42721418-42951525,19:42733459-43286626,19:42788811-43044850,19:42838106-42943182,19:42847842-42907051,19:42857733-43193181,19:42878950-43042247,19:42908380-42950466,19:42918190-43344645,19:42951426-43044850;Span2=425298,230108,553168,256040,105077,59210,335449,163298,42087,426456,93425;OverlapType=Within Region,Partial Overlap,Within Region,Within Region,Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap;Name=gssvL58685,gssvL58691,gssvL58684,gssvL58690,gssvL58698,gssvL58711,gssvL58687,gssvL58693,gssvL58719,gssvL58686,gssvL58699;Frequency=0.0288,0.0097,0.0139,0.0066,0.0107,0.0347,0.006,0.0085,0.03,0.0112,0.004;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=19:42786043-43283767,19:42804715-43042993,19:42814908-42983514,19:42864784-42911572,19:42903935-42936018,19:42908102-43039444,19:42953903-43038679,19:42973627-43023472;Span3=497725,238279,168607,46789,32084,131343,84777,49846;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.00951374,0.025,0.0243129,0.000168947,0.00710059,0.0035503,0.00405474,0.0035503;DeletionFrequency=0.00951374,0.025,0.0243129,0.000168947,0.00710059,0.0035503,0.00405474,0.0035503;DuplicationFrequency=0,0,0,0,0,0,0,0;END=43026416	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:118.719:-2.5773:0.616245:2.01600143380136e-29:PSG1,PSG6,PSG7,PSG11::PSG1:NM_001184825.2:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37483inClinGenDosageSensitivity.,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
19	44905836	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=APOE;GeneIDs=348;Aliases=AD2,APO-E,ApoE4,LDLCQ5,LPG;Genes=1;TranscriptNameClinicallyRelevant=NM_000041.4;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000019.10:g.44905836_44905955dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.32;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=44905955	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.967:4.64406:1.75488:0.000187879088160265:APOE::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
20	45899575	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=342;GeneNames=PLTP;GeneIDs=5360;Aliases=BPIFE,HDLCQ9;Genes=1;TranscriptNameClinicallyRelevant=NM_006227.4;OverlappingExonsClinicallyRelevant=13-14;HGVSg=NC_000020.11:g.45899575_45899916dup;HGVScClinicallyRelevant=NM_006227.4:c.1176-38_1283-37dup;HGVSpClinicallyRelevant=NP_006218.1:p.E428Gfs*16;ISCNCytobandNotation=dup(20)q13.12;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=45899916	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:121.788:3.45579:1.38841:8.45483459655331e-05:PLTP::PLTP:NM_006227.4:VUS:2L0ThiscnvpartiallyoverlapsthePLTPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	19881002	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=4;Span=17143;GeneNames=TXNRD2;GeneIDs=10587;Aliases=GCCD5,SELZ,TR,TR-BETA,TR3,TRXR2;Genes=1;TranscriptNameClinicallyRelevant=NM_006440.5;OverlappingExonsClinicallyRelevant=10-12;HGVSg=NC_000022.11:g.19881002_19898144dup;HGVScClinicallyRelevant=NM_006440.5:c.683-14_1087-285dup;HGVSpClinicallyRelevant=NP_006431.2:p.G363Mfs*20;ISCNCytobandNotation=dup(22)q11.21;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=19898144	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:107.358:2.41582:1.3546:0.00010317415571999:TXNRD2::TXNRD2:NM_006440.5:VUS:2B0WhiletheCNVoverlapstheTXNRD2geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37433inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheTXNRD2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
X	49332702	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=2;Span=13218;GeneNames=GAGE12B,GAGE13;GeneIDs=645051,729428;Aliases=GAGE-12A,GAGE-13,GAGE12A;Genes=2;TranscriptNameClinicallyRelevant=NM_001127345.3,NM_001098412.4;OverlappingExonsClinicallyRelevant=1-4,2-5;HGVSg=NC_000023.11:g.49332702_49345919dup;HGVScClinicallyRelevant=NM_001127345.3:c.1_328dup,.;HGVSpClinicallyRelevant=NP_001120817.2:p.E110Dfs,.;ISCNCytobandNotation=dup(X)p11.23;SequenceOntologyClinicallyRelevant=frameshift_variant,.;RegionClinicallyRelevant=exon,.;END=49345919	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:541.425:2.22475:1.73745:0.000355317404694572:GAGE12B,GAGE13::GAGE13:NM_001098412.4:Benign:2B0WhiletheCNVoverlapstheGAGE13geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-46290inClinGenDosageSensitivity.,2G0TheCNVisoverlapsthetriplobenignregionISCA-46540inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
X	141176571	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=65177;GeneNames=LDOC1,SPANXC;GeneIDs=23641,64663;Aliases=BCUR1,Mar7,Mart7,RTL7,SIRH7;Genes=2;TranscriptNameClinicallyRelevant=NM_012317.4,NM_022661.4;OverlappingExonsClinicallyRelevant=All,2;HGVSg=NC_000023.11:g.141176571_141241747dup;HGVScClinicallyRelevant=.,NM_022661.4:c.73-9_294dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(X)q27.1-q27.2;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=141241747	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:250.236:3.40593:1.53348:0.000107237092749998:LDOC1,SPANXC::SPANXC:NM_022661.4:VUS:2L0ThiscnvpartiallyoverlapstheSPANXCgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
